National News
Lack of Diabetes Equipment Subsidies Affects Over a Million Australians
Despite continuous glucose monitors (CGMs) and insulin pumps being critical for diabetes management, over one million Australians with Type 2 diabetes are currently ineligible for government subsidies for these devices.
At present, CGMs and insulin pumps are only subsidized for Type 1 diabetes patients, forcing Type 2 patients to shoulder high out-of-pocket costs. For example, CGMs can cost $3,000 to $5,000 annually, and insulin pumps may cost up to $8,000. Many are left struggling to choose between financial stability and proper health care. One patient, 26-year-old Sammy Haigh from Newcastle, reported spending at least $5,000 a year on diabetes care, which is a significant burden.
Diabetes Australia has called on the government to expand subsidies to Type 2 patients, arguing that it would not only improve individual health outcomes but also ease pressure on the broader healthcare system. Although the federal government has reviewed reports on the issue, it has yet to respond formally.